{"data":[{"accessionNo":"0001950047-26-007278","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"NICOLAS LEUPIN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":39088,"aggregateMarketValue":608600.16,"unitsOutstanding":116445840,"approxSaleDate":"2026-07-23","exchange":"NASDAQ","filedAt":"2026-07-23"},{"accessionNo":"0001950047-26-005676","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"FRANCIS LEONARD","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":34273,"aggregateMarketValue":614634.85,"unitsOutstanding":115820940,"approxSaleDate":"2026-06-04","exchange":"NASDAQ","filedAt":"2026-06-04"},{"accessionNo":"0001950047-26-002241","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"MUKUND PARAVASTHU","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":43246,"aggregateMarketValue":595681.68,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-05"},{"accessionNo":"0001950047-26-002217","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"URI WEINBERG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6412,"aggregateMarketValue":85314.22,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04"},{"accessionNo":"0001950047-26-002215","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"MUKUND PARAVASTHU","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5377,"aggregateMarketValue":71543.14,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04"},{"accessionNo":"0001950047-26-002211","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"FRANCIS LEONARD","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5607,"aggregateMarketValue":74603.38,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04"},{"accessionNo":"0001950047-26-002218","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"CHRISTOPH BRACKMANN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6412,"aggregateMarketValue":85314.22,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-04","exchange":"NASDAQ","filedAt":"2026-03-04"},{"accessionNo":"0001950047-26-002120","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"WILLIAM DOYLE","relationship":"Officer, Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":71887,"aggregateMarketValue":932884.79,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-03","exchange":"NASDAQ","filedAt":"2026-03-03"},{"accessionNo":"0001950047-26-001960","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"URI WEINBERG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3272,"aggregateMarketValue":43606.93,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001950047-26-002042","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"FRANCIS LEONARD","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7232,"aggregateMarketValue":97581.38,"unitsOutstanding":113794396,"approxSaleDate":"2026-03-02","exchange":"NASDAQ","filedAt":"2026-03-02"},{"accessionNo":"0001950047-26-001890","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"URI WEINBERG","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7461,"aggregateMarketValue":103256.51,"unitsOutstanding":113794396,"approxSaleDate":"2026-02-27","exchange":"NASDAQ","filedAt":"2026-02-27"},{"accessionNo":"0001950047-26-001911","issuerCik":"0001645113","issuerName":"NovoCure Limited","ticker":"NVCR","personName":"FRANCIS LEONARD","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9734,"aggregateMarketValue":133003.43,"unitsOutstanding":113794396,"approxSaleDate":"2026-02-27","exchange":"NASDAQ","filedAt":"2026-02-27"}],"updatedAt":"2026-09-19T01:25:48.675Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}